Thrombogenicity

This article needs more primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Thrombogenicity" – news · newspapers · books · scholar · JSTOR (November 2021)

Thrombogenicity refers to the tendency of a material in contact with the blood to produce a

are available to minimize these thrombogenic effects.

A thrombogenic implant will eventually be covered by a fibrous capsule, the thickness of this capsule can be considered one measure of thrombogenicity, and if extreme can lead to the failure of the implant.

See also

• Endothelial activation

References

Further reading

• Paul, R; Marseille, O; Hintze, E; Huber, L; Schima, H; Reul, H; Rau, G (1998). "In vitro thrombogenicity testing of artificial organs". The International Journal of Artificial Organs. 21 (9): 548–52.
  S2CID 21180052
  .
• Kenny, DA; Berger, K; Walker, MW; Robel, SB; Boguslavsky, L; Ray, LI; Lischko, MM; Sauvage, LR (1980). "Experimental comparison of the thrombogenicity of fibrin and PTFE flow surfaces". Annals of Surgery. 191 (3): 355–61.
  PMID 6444800
  .

This hematology article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e